Abstract | AIM: RESULTS: We fractionated left ventricle (LV) samples using a differential solubility-based approach. The insoluble protein fraction was analyzed by mass spectrometry, and we identified CS as a potential intracellular substrate of MMP-9 in the MI setting. CS protein levels increased in the insoluble fraction at day 1 post-MI in both genotypes (p<0.05) but not in the noninfarcted remote region. The CS activity decreased in the infarcted tissue of wild-type (WT) mice at day 1 post-MI (p<0.05), but this was not observed in the MMP-9 null mice, suggesting that MMP-9 deletion helps to maintain the mitochondrial activity post-MI. Additionally, inflammatory gene transcription was increased post-MI in the WT mice and attenuated in the MMP-9 null mice. MMP-9 cleaved CS in vitro, generating an ∼20 kDa fragment. INNOVATION: By applying a sample fractionation and proteomics approach, we were able to identify a novel MMP-9-related altered mitochondrial metabolic activity early post-MI. CONCLUSION: Our data suggest that MMP-9 deletion improves mitochondrial function post-MI.
|
Authors | Lisandra E de Castro Brás, Courtney A Cates, Kristine Y DeLeon-Pennell, Yonggang Ma, Rugmani Padmanabhan Iyer, Ganesh V Halade, Andriy Yabluchanskiy, Gregg B Fields, Susan T Weintraub, Merry L Lindsey |
Journal | Antioxidants & redox signaling
(Antioxid Redox Signal)
Vol. 21
Issue 14
Pg. 1974-85
(Nov 10 2014)
ISSN: 1557-7716 [Electronic] United States |
PMID | 24382150
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Citrate (si)-Synthase
- Matrix Metalloproteinase 9
|
Topics |
- Animals
- Citrate (si)-Synthase
(metabolism)
- Heart Ventricles
(metabolism, pathology)
- Humans
- Matrix Metalloproteinase 9
(genetics, metabolism)
- Mice
- Mice, Knockout
- Mitochondria
(metabolism, pathology)
- Myocardial Infarction
(metabolism, pathology)
|